Dylan Pashley
Biographic Data
| ID | 5099626 |
|---|---|
| NAME | Dylan Pashley |
| GIVEN NAMES | Dylan |
| FAMILY NAME | Pashley |
| SIGNATURE | PASHLEY D |
| AFFILIATIONS | Lund University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Patterns of company misconduct, recidivism, and complaint resolution delays
Interfirm self‐regulation through trade associations is common but its effectiveness is debated and likely varies by time, country, and industry. This study examines self‐regulation of pharmaceutical marketing, characterized by delegation of major regulatory responsibilities to trade associations' self‐regulatory bodies. In addressing critical research gaps, this study first analyzes 1,776 complaints against pharmaceutical companies in the UK ove…
Advancing international comparison of pharmaceutical industry funding of patient advocacy
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patient engagement in healthcare due to fears of commercial agendas influencing patient advocacy and creating industry-driven inequalities across patient organizations. We contribute to an international body of knowledge on patient organization-industry relations by analyzing all payments reported by companies in Denmark over a six-year period, 2014-2019…
Patterns of company misconduct, recidivism, and complaint resolution delays
Interfirm self‐regulation through trade associations is common but its effectiveness is debated and likely varies by time, country, and industry. This study examines self‐regulation of pharmaceutical marketing, characterized by delegation of major regulatory responsibilities to trade associations' self‐regulatory bodies. In addressing critical research gaps, this study first analyzes 1,776 complaints against pharmaceutical companies in the UK ove…
Advancing international comparison of pharmaceutical industry funding of patient advocacy
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patient engagement in healthcare due to fears of commercial agendas influencing patient advocacy and creating industry-driven inequalities across patient organizations. We contribute to an international body of knowledge on patient organization-industry relations by analyzing all payments reported by companies in Denmark over a six-year period, 2014-2019…
Patterns of company misconduct, recidivism, and complaint resolution delays
Interfirm self‐regulation through trade associations is common but its effectiveness is debated and likely varies by time, country, and industry. This study examines self‐regulation of pharmaceutical marketing, characterized by delegation of major regulatory responsibilities to trade associations' self‐regulatory bodies. In addressing critical research gaps, this study first analyzes 1,776 complaints against pharmaceutical companies in the UK ove…
Business (2 works) · Medicine (2 works) · Pharmaceutical industry (2 works) · Pharmaceutical industry and healthcare (2 works) · Political science (2 works) · Accounting (1 work) · Biosimilar (1 work) · Complaint (1 work) · Context (archaeology (1 work) · Criminology (1 work)